Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
65.80    0.90 (1.39%)
Bid:
65.40
Ask:
65.60
Spread: 0.20 (0.306%)
Market Cap: £581.30m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Directorate Change

14 Dec 2017 16:48

RNS Number : 4224Z
IP Group PLC
14 December 2017
 

FOR RELEASE ON

14 December 2017

 

 

IP Group plc - Retirement of Non-executive Director

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), a leading developer of intellectual property-based businesses, announces that Doug Liversidge, CBE, will retire from his position as a non-executive director of the Company at the end of the year.

 

Mr Liversidge has served on the Board in a non-executive capacity since March 2014 following IP Group's acquisition of Fusion IP plc, where he was Chairman. He became Senior Independent Director of IP Group in March 2015.

 

Professor David Begg, who was appointed as a non-executive director in October 2017, will become Senior Independent Director with effect from 1 January 2018.

 

Mike Humphrey, Non-executive Chairman, said: "I would like to thank Doug both for his contribution to the Group and his wise counsel. He has played an important role in aiding the successful integration of Fusion IP and the Group's growth since that time and we wish him all the very best in his retirement."

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

Martha Walsh

+44 (0) 7810 636995

+44 (0) 7876 245962

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across four main sectors -- Biotech, Cleantech, Healthcare and Technology. The Company, which recently announced the acquisition of Touchstone Innovations plc, is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOATIBFTMBIBBIR
Date   Source Headline
12th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20255:40 pmRNSTransaction in Own Shares
7th Feb 20255:48 pmRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20256:21 pmRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:01 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20255:59 pmRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20256:08 pmRNSTransaction in Own Shares
21st Jan 20256:21 pmRNSTransaction in Own Shares
20th Jan 20256:00 pmRNSTransaction in Own Shares
17th Jan 20256:17 pmRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20255:34 pmRNSTransaction in Own Shares
15th Jan 20253:21 pmRNSForm 8.3 - Tissue Regenix Group plc
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20256:02 pmRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSShare buyback programme update
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20255:43 pmRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTotal Voting Rights
20th Dec 20245:09 pmRNSTransaction in Own Shares
20th Dec 20241:46 pmRNSForm 8.3 - Intelligent Ultrasound Group plc
20th Dec 20247:00 amRNS-RTwo life sciences companies receive cash offers
20th Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20241:10 pmRNS£119m initial cash after sale of Featurespace
18th Dec 20246:26 pmRNSTransaction in Own Shares
18th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20244:55 pmRNSTransaction in Own Shares
13th Dec 20245:59 pmRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSAGM post-meeting shareholder engagement update
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20242:44 pmRNSHolding(s) in Company
9th Dec 202412:00 pmRNSHolding(s) in Company
9th Dec 20247:00 amRNSSecondary sale of minority holdings in portfolio
6th Dec 20245:13 pmRNSTransaction in Own Shares
6th Dec 20241:57 pmRNSForm 8.3 - Tissue Regenix Group plc
6th Dec 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.